Margaret Dalesandro
Director/Board Member bei SKYE BIOSCIENCE, INC.
Vermögen: 690 $ am 31.03.2024
Profil
Margaret R.
Dalesandro is the founder and currently holds multiple positions.
She founded Brecon Pharma Consulting LLC in 2012 and serves as the President.
Additionally, Dr. Dalesandro currently holds the following positions: Independent Director at Skye Bioscience, Inc. since 2020, Director at Emerald Health Bioceuticals, Inc. since 2020, Independent Director at Seelos Therapeutics, Inc. since 2021, and Independent Director at Ambrx Biopharma Cayman, Inc. since 2023.
Dr. Dalesandro has held former positions as well.
She was the Director of Immunobiology & Diagnostic Research at Centocor, Inc. from 1989 to 1998.
From 2009 to 2012, she served as the Business Director of Integrative Pharmacology at Corning, Inc. Dr. Dalesandro was also an Independent Director at OncoSec Medical, Inc. from 2019 to 2020.
She held the position of Executive Director of Project & Portfolio Management at GSK Plc from 2000 to 2002.
Additionally, Dr. Dalesandro was the VP of Project, Portfolio & Alliance Management at ImClone LLC from 2002 to 2009.
She also served as an Independent Director at Ambrx Biopharma, Inc. from 2023 to 2024.
In terms of education, Dr. Dalesandro holds a graduate degree and a doctorate from Bryn Mawr College.
She also has an undergraduate degree from Rosemont College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.01.2024 | 1 167 ( 0,01% ) | 690 $ | 31.03.2024 | |
SKYE BIOSCIENCE, INC.
-.--% | 29.02.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Margaret Dalesandro
| Unternehmen | Position | Beginn |
|---|---|---|
| SKYE BIOSCIENCE, INC. | Director/Board Member | 07.08.2020 |
| SEELOS THERAPEUTICS, INC. | Director/Board Member | 01.09.2021 |
| Brecon Pharma Consulting LLC | Founder | 01.09.2012 |
Emerald Health Bioceuticals, Inc.
 Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Emerald Health Bioceuticals, Inc. engages in the provision of research and development of cannabis-free nutritional supplements that support the body’s endocannabinoid system (ECS). Its products include Endo Omega, Endo OmegaVegan, Endo Immune, Endo Sleep, Endo Bliss, Endo Calm, Endo Inflame, and Endo Brain. The company was founded on March 27, 2015 and is headquartered in San Diego, CA. | Director/Board Member | 01.02.2020 |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Director/Board Member | 01.09.2023 |
Ehemalige bekannte Positionen von Margaret Dalesandro
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Chief Executive Officer | 13.12.2021 |
| CORNING INCORPORATED | Corporate Officer/Principal | 01.01.2012 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01.01.2009 |
| GSK PLC | Corporate Officer/Principal | 01.01.2002 |
Ausbildung von Margaret Dalesandro
| Bryn Mawr College | Doctorate Degree |
| Rosemont College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| CORNING INCORPORATED | Electronic Technology |
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| GSK PLC | Health Technology |
| SKYE BIOSCIENCE, INC. | Health Technology |
| SEELOS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Emerald Health Bioceuticals, Inc.
Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Emerald Health Bioceuticals, Inc. engages in the provision of research and development of cannabis-free nutritional supplements that support the body’s endocannabinoid system (ECS). Its products include Endo Omega, Endo OmegaVegan, Endo Immune, Endo Sleep, Endo Bliss, Endo Calm, Endo Inflame, and Endo Brain. The company was founded on March 27, 2015 and is headquartered in San Diego, CA. | Health Technology |
| Brecon Pharma Consulting LLC | |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
